The landscape of metastatic breast cancer (MBC) research has undergone a significant transformation, marked by a surge...
Metastatic Breast Cancer Research
Introduction: The State of the Mission As the 2026 grant cycle officially commences, METAvivor—a leading voice in...
March 2026 – As the first quarter of 2026 draws to a close, METAvivor, the leading advocate...
Introduction: The Dual Burden of Advocacy and Personal Survival For Dr. Kelly Shanahan, the boundary between professional...
Introduction: The Advocacy Imperative In the ongoing evolution of the COVID-19 pandemic, the landscape of public health...
The landscape of oncology is witnessing a transformative shift as a new cohort of distinguished researchers receives...
Executive Summary: A Month of Legislative Mobilization February has proven to be a pivotal month for METAvivor,...
By Editorial Staff In the high-stakes world of medical research, the intersection of patient advocacy and scientific...
By the METAvivor Advocacy Team As the legislative calendar accelerates following the conclusion of the April congressional...
Introduction: The Unpredictable Nature of MBC For Kelly Shanahan, M.D., the President of METAvivor, life with metastatic...
